• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

ChoiceSpine™ Announces Line Extension of TigerShark™ Lateral Interbody System

October 2, 2025 By SPINEMarketGroup

KNOXVILLE, Tenn.–(BUSINESS WIRE)–ChoiceSpine LLC, a provider of differentiated spine surgery systems proudly announces the launch of a significant line extension for their TigerShark Lateral Interbody System. Developed in close collaboration with Stuart D. Kinsella, MD, MSTR of The Steadman Clinic, the expanded implant offering is designed to accommodate a broader range of patient anatomies.

TigerShark Lateral incorporates ChoiceSpine’s proprietary BioBond® porous trabecular structure, which utilizes additive manufacturing (3D Printing) to create distinct and intentionally designed submicron, micro, and macro interconnected architecture to optimize surface contact, load sharing, and osseointegration potential. Building on an already successful product line, the expanded implant size portfolio with additional incremental heights offers more precise intervertebral reconstruction to meet the diverse anatomical and clinical needs encountered in a lateral lumbar interbody fusion procedure.

“This line extension reflects a meaningful step forward in tailoring spine surgery to each individual patient,” said Stuart D. Kinsella, MD, MSTR. “We now have more personalized tools to achieve our surgical goals that can match the patient’s unique spinal profile.”

“By working closely with our surgeon partners, we continue to design solutions that more precisely address the real-world variability in patient anatomy,” said Stephen Ainsworth, Ph.D., ChoiceSpine’s Co-President. “This collaboration ensures that our technology evolves in step with the clinical challenges and opportunities faced in modern spine surgery.”

The features of the TigerShark Lateral Interbody system include:

  • BioBond proprietary porous trabecular structure created with additive manufacturing (3D printing)
  • Three lordotic options for each interbody footprint: 0°, 6°, and 12°
  • Large central openings and deep perimeter cuts that help maximize the volume for bone graft material placement
  • Excellent visibility under fluoroscopy

ChoiceSpine LLC is a spinal device company located in Knoxville, TN, privately held by Altus Capital Partners. ChoiceSpine prides itself on providing excellent products aimed at improving people’s lives through a positive customer experience. Here at ChoiceSpine, we offer a variety of surgeon-focused product lines that are designed to be safe, efficient, and easy to use. By focusing on a collaborative team approach with physicians and industry partners, ChoiceSpine continues to deliver upon product commitments, maintain cutting-edge research and development, and bring technically superior products to the forefront of the spinal implant industry. For more information, please visit www.choicespine.com.

Altus Capital Partners is a private equity firm that makes control investments in middle-market niche-manufacturing businesses. Our exclusive focus on manufacturing provides us with a unique understanding of the opportunities and challenges faced by companies in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. For more information, please visit www.altuscapitalpartners.com.

Contacts

Ron Moore
Sr. Director of Marketing
865-246-3333
rmoore@choicespine.com
choicespine.com

Filed Under: LAUNCHES, NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMMED
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
logo paradigm spine

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • PRODUCT LIBRARY
  • Expandable cages were adopted not because they fused…
  • Medical Device Correction Addresses Loss of Lordosis…
  • Who Is Really Winning the Mid-Tier Spine…
  • Medtronic Named in Florida Lawsuit Over Alleged…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • Johnson & Johnson Explores Potential $20B Sale…
  • Medtronic receives FDA clearance for Stealth AXiS™…
  • Why Expandable Cages Sometimes Lose Lordosis After…
  • Seven Leading Augmented (AR) and Extended Reality…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Medtronic Korea Launches Kanghui, a New…
  • Globus Medical Reports Fourth Quarter and Full Year…
  • Most Spine Failures Are Predictable — The Bone…
  • ATEC Announces Select Preliminary Financial Results…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • 2025 Spine Product Launches and Trends: Where is the…
  • VB Spine to Acquire Intraoperative Visualization…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • What Is Medtronic’s PILAR™ Technique?
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • From Early Innovations to Modern Practice: Where Are…
  • From Niche to Momentum: The Rapid Rise of Spinal…
  • Loyalty in the Spine Industry: Real, Valuable… and…
  • VB Spine Announces Successful First Clinical Cases…
  • LAST 5 VIDEOS PUBLISHED

    1. SI-BONE: iFuse INTRA Ti™ Implant System
    2. Globus Medical: IntraLIF™ Cannulated
    3. SI-BONE: iFuse TORQ TNT® Implant System
    4. Globus Medical: VICTORY™ Lumbar Plate
    5. Alphatec Spine: ASCEND™ VBR 12mm

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2026 · SPINEMarketGroup